Combinative treatment of Curdione and docetaxel triggers reactive oxygen species (ROS)-mediated intrinsic apoptosis of triple-negative breast cancer cells-Reference-Cited by-同舟云学术

Combinative treatment of Curdione and docetaxel triggers reactive oxygen species (ROS)-mediated intrinsic apoptosis of triple-negative breast cancer cells

Published:2021-12-02 Issue:2 Volume:12 Page:10037-10048
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Wang Changcheng¹,Guo Jia¹,Wu Zeng’An¹

Affiliation:

1. Division of General Surgery, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China

Funder

funding associated with the work featured in this

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2021.1994737

Reference47 articles.

1. Triple-negative breast cancer molecular subtyping and treatment progress

2. Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies

3. Non-coding RNA profile in lung cancer

4. Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress on the role of reactive oxygen species in the initiation, development and treatment of breast cancer;Progress in Biophysics and Molecular Biology;2024-05

2. In vitro inhibition of six active sesquiterpenoids in zedoary turmeric oil on human liver cytochrome P450 enzymes;Journal of Ethnopharmacology;2024-03

3. Effect and Mechanism of Curdione Combined with Gemcitabine on Migration and Invasion of Bladder Cancer;Biochemical Genetics;2023-12-05

4. Curdione induces ferroptosis mediated by m6A methylation via METTL14 and YTHDF2 in colorectal cancer;Chinese Medicine;2023-09-21

5. Potential roles and molecular mechanisms of bioactive ingredients in Curcumae Rhizoma against breast cancer;Phytomedicine;2023-06